Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. (2022)


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0275927

PubMed Identifier: 36327320

Publication URI: http://europepmc.org/abstract/MED/36327320

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 11

ISSN: 1932-6203